Pipeline Accelerator 2025-26 Round 1 Outcomes
16 December 2025 Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia, Bioplatforms Australia and ANSTO’s National Deuteration Facility, is thrilled to announce the successful recipients of the Pipeline Accelerator 2025-26 (Round 1). Enabled by the National Collaborative Research Infrastructure Strategy (NCRIS), these four NCRIS providers are working in partnership to help address the medical products challenge outlined […]
How NCRIS infrastructure helped UQ’s vaccine platform – a billion-dollar success
16 December 2025 A landmark deal has placed Australian vaccine innovation on the world stage, with leading healthcare company Sanofi completing the acquisition of Vicebio Molecular Clamp inventors Prof Keith Chappell, Prof Daniel Watterson and Em Prof Paul Young (Photo credit: The University of Queensland ) Vicebio was formed in 2019 to advance The University […]
Pipeline Accelerator 2024-25 Round 2 Outcomes
24 June 2025 Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia, Bioplatforms Australia and ANSTO’s National Deuteration Facility, is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 2). Enabled by the National Collaborative Research Infrastructure Strategy (NCRIS), all four NCRIS providers mentioned above are working together to help address the medical products challenge […]
NCRIS Turbo-Charges New mRNA Drugs
Therapeutics that use mRNA are a growing area of development and work by introducing the ‘’message” to make a therapeutic protein into the patient’s body, instead of the protein itself. This approach can revolutionise combatting many kinds of cancers, and for treating genetic and infectious diseases. Conventional strategies deliver mRNA drugs to tissues inside lipid […]
Pipeline Accelerator Voucher Recipients Announced
Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia and the National Deuteration Facility (NDF), is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 1). Supported through the National Collaborative Research Infrastructure Strategy (NCRIS), this initiative helps address the medical products challenge outlined in the 2021 National Research Infrastructure (NRI) Roadmap. […]
NCRIS Health welcomes the Australia RNA Blueprint
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint by the Australian Department of Industry, Science and Resources. The NCRIS Health Group includes Bioplatforms Australia, EMBL Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia. We are delighted that our advanced translational research infrastructure has been recognised […]
Therapeutic Innovation Australia and Phenomics Australia partnership reinforces commitment to address the medical products challenge
In partnership with Phenomics Australia (PA), Therapeutic Innovation Australia (TIA) is pleased to announce the successful recipients of the Pipeline Accelerator 2023-24 (Round 2). Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, TIA and PA support a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure […]
TIA launches new RNA Products Capability
On May 24, 2024, TIA launched of its groundbreaking RNA Products Capability at UNSW, with the assistance of NSW Senator Tim Ayres, Chief Scientist Cathy Foley and UNSW Vice Chancellor Atilla Brungs. This new capability is supported by funding from the National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Department of Education. It aims […]
Funding boost from two state governments to enhance translational research infrastructure
Funding boost from two state governments to enhance translational research infrastructure TIA is thrilled to announce that we have secured over $5.5M in funding from the New South Wales (NSW) and Queensland Governments through the NCRIS Support Program and Research Infrastructure Co-Investment Fund (RICF), respectively. Under the NSW NCRIS Support Program, researchers and industries […]